← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2013Last known activity
Jun 30, 2025
Timeline
2000s
- Jun 1, 2007
NGM Biopharmaceuticals, Inc— Founded
Drugs by trial phase (10 distinct, 26 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Recent trials (48)
- NCT07033026OfficialPhase 2Jun 30, 2025
- NCT07033026Lead sponsorPhase 2Jun 30, 2025
- NCT06654726Lead sponsorPhase 2/Phase 3Oct 21, 2024
- NCT05311618Lead sponsorPhase 1May 11, 2022
- NCT05215574Lead sponsorPhase 1Mar 31, 2022
- NCT05130047CollaboratorPhase 2Nov 30, 2021
- NCT04913337Lead sponsorPhase 1/Phase 2Jun 9, 2021
- NCT04823702Lead sponsorPhase 1Apr 1, 2021
- NCT04823702Study directorPhase 1Apr 1, 2021
- NCT04828265Lead sponsorPhase 1Apr 1, 2021
- NCT04828265Study directorPhase 1Apr 1, 2021
- NCT04582318Lead sponsorPhase 1/Phase 2Nov 8, 2020
- NCT04465955Study directorPhase 2Jul 22, 2020
- NCT04465955Lead sponsorPhase 2Jul 22, 2020
- NCT04187339Lead sponsorPhase 1Feb 29, 2020
Details
- Founded
- South San Francisco, CA, US Jun 1, 2007
- Last known activity
- Jun 30, 2025